These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9397197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases.
    Berruti A, Dogliotti L, Gorzegno G, Torta M, Tampellini M, Tucci M, Cerutti S, Frezet MM, Stivanello M, Sacchetto G, Angeli A.
    Clin Chem; 1999 Aug; 45(8 Pt 1):1240-7. PubMed ID: 10430790
    [Abstract] [Full Text] [Related]

  • 6. Palliative treatment of bone metastases in hormone-refractory prostate cancer: effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels.
    Kawashima H, Tanaka T, Kuratsukuri K, Uchida J, Sugimura K, Tamada S, Nishisaka N, Kumata K, Iwai Y, Ikemoto S, Ezaki K, Nakatani T.
    Urol Int; 2007 Aug; 78(4):345-50. PubMed ID: 17495494
    [Abstract] [Full Text] [Related]

  • 7. Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer.
    Murray RM, Grill V, Crinis N, Ho PW, Davison J, Pitt P.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4133-8. PubMed ID: 11549639
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Lu KC, Yeung LK, Lin SH, Lin YF, Chu P.
    Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
    [Abstract] [Full Text] [Related]

  • 11. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ, Bravo Soto JA, Merino Pérez MJ, González Carmelo I, López Jiménez V, García Álvarez T, Acosta Martínez Y, Mazuecos Blanca MA.
    Nefrologia; 2015 Dec; 35(4):363-73. PubMed ID: 26306956
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.
    Cremers SC, Papapoulos SE, Gelderblom H, Seynaeve C, den Hartigh J, Vermeij P, van der Rijt CC, van Zuylen L.
    J Bone Miner Res; 2005 Sep; 20(9):1543-7. PubMed ID: 16059626
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases.
    Schwartz GG.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):478-83. PubMed ID: 18349265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyperparathyroidism due to the so-called bone hunger syndrome in prostate cancer patients.
    Berruti A, Dogliotti L, Tucci M, Scarpa RM, Angeli A.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1910-1; author reply 1911. PubMed ID: 11932346
    [No Abstract] [Full Text] [Related]

  • 20. Osteomalacia associated with prostatic cancer and osteoblastic metastases.
    Kabadi UM.
    Urology; 1983 Jan; 21(1):65-7. PubMed ID: 6687413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.